Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLE
NCT00553410Phase 3Completed
- Sponsor
- ETOP IBCSG Partners Foundation
- Start
- Aug 2007
- Primary completion
- Apr 2018
- Modality
- Orthosteric Ligands
- Countries
- 20
01
Overview
A Phase 3 trial of letrozole in breast cancer, sponsored by ETOP IBCSG Partners Foundation. Started Aug 2007; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00553410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553410.